Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome (Q84070917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

1 reference

Shuichi Ito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Koichi Kamei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Masao Ogura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Mai Sato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Takuya Fujimaru

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Tomoaki Ishikawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Tomohiro Udagawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kazumoto Iijima

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

10 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

1823-1828

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556716%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-011-1886-x

31 January 2020

exact match

0 references

cites work

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

1 reference

12 December 2020

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

1 reference

12 December 2020

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Rituximab efficiency in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods

1 reference

12 December 2020

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

1 reference

12 December 2020

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

1 reference

12 December 2020

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

1 reference

12 December 2020

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

1 reference

12 December 2020

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

1 reference

12 December 2020

Fatal pulmonary fibrosis after rituximab administration

1 reference

12 December 2020

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

1 reference

12 December 2020

Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.

1 reference

12 December 2020

A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome

1 reference

12 December 2020

Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab

1 reference

12 December 2020

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

1 reference

12 December 2020